MedTrace Logo

Double Unit Cord Blood Transplant in Hematologic Malignancies.

NCT06712108 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-02-02

No results posted yet for this study

Summary

The efficacy and safety of non-myeloablative and myeloablative preconditioning followed by dual-unit umbilical cord blood transplantation from unrelated donors in adult patients with malignant hematologic diseases eligible for allogeneic hematopoietic stem cell transplantation are evaluated through prospective observation and analysis of actual clinical data collection

Conditions

  • Adult Double Unit Cord Blood Transplant

Interventions

PROCEDURE

tranplant

double unit cord blood transplnat

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Dong-Yeop Shin, MD, PhD. · Seoul National University Hospital

  • Sung-Soo Yoon, MD, PhD. · Seoul National University Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-21
Primary Completion
2030-03-31
Completion
2030-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06712108 on ClinicalTrials.gov